Abstract Submission Guidelines

Abstract submission for the HTAi 2020 Annual Meeting is now closed


Table of Contents

  1. Overall Scientific Theme and Program
  2. Abstract Submissions
  3. General Information
  4. Scoring Criteria
  5. Style Guidelines
  6. FAQs


Researchers, agencies, policy makers, industry, academia, health service providers and patients/consumers meet to build international cooperation and to face new challenges together.


Overall Scientific Theme and Program

Attaining, Maintaining, and Sustaining Healthcare Systems in a Changing World: The Role of HTA

The HTAi 2020 Annual Meeting to be held in Beijing, China will focus on the roles that Health Technology Assessment (HTA) can play in improving outcomes while sustaining health systems.

Attaining Universal Health Coverage (UHC) is a pressing issue for many countries, particularly those with lower and middle incomes. HTA is a recognized tool for priority setting, making evidence-based resource allocation decisions and developing benefits packages to help achieve UHC. We also know that in these health systems and in countries that have achieved UHC, HTA plays an ongoing role in progressing UHC and the sustainability of the health systems.

However, current developments are challenging and changing treatment and epidemiological paradigms. Prominent examples include ‘disruptive’ technologies, such as cell and gene therapy, and the incoming data tide, including increased utilization of existing real-time data sources (like wearables), and modern technologies such as artificial intelligence, blockchain, and big data architecture.  The consequences for HTA and the need to adapt is apparent, and must be faced globally to ensure the continued sustainability of health systems in 2020 and beyond.

The Plenary themes for the HTAi 2020 Annual Meeting are therefore as follows:

Plenary 1:   The Role of HTA in Achieving and Progressing Universal Health Coverage

Plenary 2:   How to Adapt HTA to Address Technologies That Are ‘Disrupting’ Health Systems

Plenary 3:   Incoming Tides and What it Means for HTA; the Rise of Real-World Evidence, ‘Big Data’, and Artificial Intelligence.


The Annual Meeting in Beijing will provide an opportunity to consider the following themes and topics in workshops, panels, oral presentations, vignettes, and posters:


The Role of HTA in Achieving and Progressing Universal Health Coverage

There is consensus that Universal Health Coverage (UHC) will improve health service coverage, with the overall health of a population bringing economic benefits as a result. HTA has a recognized role in achieving UHC. For example, in the context of priority setting: determining benefits packages, horizon scanning, and reassessment/disinvestment of existing technologies. There are many hurdles to overcome and HTA is not the only solution to a complex issue with local contextual considerations. There is no “one size fits all” when it comes to using HTA in the context of achieving UHC, and the factors that work well should be explored.

For more details on Plenary 1, please follow this link.


How to Adapt HTA to Address Technologies That Are ‘Disrupting’ Health Systems

There are an increasing number of potentially ground-breaking technologies that are fundamentally shifting how health care is provided across the world. These innovative technologies are typically expensive and are challenging the traditional HTA frameworks. Critical assessment of the current HTA frameworks is required to ascertain if they are sufficient to appraise these technologies, taking into account the potential limitations in evidence, levels of uncertainty, and policy implications (such as regulatory issues, patenting, pricing, service level readiness plus ethical, legal, social, and patient/citizen concerns). The role of HTA in horizon scanning for these technologies is almost important. Ultimately, ensuring the sustainability of health systems while providing access to potentially ground-breaking technologies is key.

For more details on Plenary 2, please follow this link.


Incoming Tides and What it Means for HTA; the Rise of Real-World Evidence, ‘Big Data’ and Artificial Intelligence.

Due to the recent surge in technological capabilities globally, the prevalence and uses of real-world evidence (RWE), ‘big data’ and artificial intelligence (AI) have been rapidly increasing. These evolving modalities of data collection and analysis are already having a profound effect on health systems around the world and, so too, on HTA. The implications for HTA involve not only how to assess clinical decision making that has been derived from these data but also how to incorporate these data and modalities into HTA processes and methodologies. The HTA community will need to effectively collaborate with technology developers, prepare the HTA workforce and maintain the sustainability of health systems while facing the ‘incoming data tide’.

For more details on Plenary 3, please follow this link.


Abstract Submissions

When submitting abstracts, applicants will be asked to select topic areas from the list below to identify the one that most closely matches the theme of their abstract. Reviewers will identify their area of expertise based on this same list of topics — this ensures that knowledgeable reviewers assess all abstracts.

As the conference focuses on Attaining, Maintaining, and Sustaining Health Systems in a Changing World: The Role of HTA, it is recommended to submit abstracts leaning on one of the plenary themes. For example, universal health coverage, disruptive health technologies, incoming data tides, etc.

HTAi will also look to ensure that at the conference there is a strong presence of patients, students, and presenters from Low and Middle-Income Countries (LMIC).

List of topic areas for abstracts:

a) Methods and Processes in HTA

  1. Research on HTA Methods, Including Novel Methods for Conducting HTA
    (e.g., Rapid Reviews, Adapting Existing HTAs, Integrated HTA)
  2. Horizon Scanning
  3. HTA Prioritization
  4. Information Retrieval
  5. Evidence Quality Including Rating/Grading, Bias, Transferability and Generalizability
  6. Clinical Effectiveness
  7. Patient Preferences
  8. Real World Data/Evidence and Big Data Analysis in HTA
  9. Economic Evaluation (Cost-Effectiveness, Cost-Benefit, Budget Impact, etc.)
  10. Ethical, Social, Cultural, Legal, Organizational and Environmental Aspects of HTA
  11. Deliberative Processes (e.g. Citizen’s Juries, Citizen’s Councils, Delphi Panels, Consensus Meetings, Advisory Committees, etc.)
  12. Measuring the Impact of HTA
  13. Reassessment and Disinvestment

b) Policy Issues In HTA

  1. Globalization
  2. Regulatory-HTA Alignment
  3. Value-Based Health Policy and Value Frameworks
  4. Translating HTA Findings into Policy and Practice (Including Evidence-to-Decision Frameworks)
  5. Capacity Building in HTA, Enhancing Skills and Capabilities at Country Level
  6. Country-Specific HTA and Regional HTA Networks
  7. Comparative HTA Systems and Emerging Markets

c) Hospital-Based HTA

  1. HTA and Procurement
  2. HTA and Health Technology Management

d) HTA and Clinical Practice Guidelines

e) Stakeholder Involvement in HTA

  1. Patient Involvement
  2. Public Involvement
  3. HTA and Shared Decision-Making
  4. Engagement of Health Care Professionals
  5. HTA in the Media and Including Specialist and General Media and Social Media

f) HTA Findings

  1. Pharmaceuticals and Biologics (Including Genetic Therapies, Immunotherapies, etc.)
  2. Medical Devices
  3. Public Health Interventions (e.g. Screening Programs, Immunization Programs)
  4. Procedures and Other Interventions (e.g. Surgery, Non-Pharmacological/Non-Device Interventions)
  5. Tests: Screening, Predictive, Diagnostic, Companion Diagnostics, Biomarkers, etc.)
  6. Social Services
  7. Electronic-Health and Mobile-Health (e.g. wearable tracking devices)

g) Other topics

Workshop and Panel Submissions
Oral, Vignette, and Poster Submissions

General Information

Submission deadlines

Submission deadlines are different based on submission type. Please note the important dates regarding abstract submissions, listed below. No extensions will be made to these deadlines under any circumstances.

Open Call for Abstracts: August 19, 2019

Deadline for Workshop and Panel submissions: October 10, 2019
Acceptance notification: November 11, 2019

Deadline for Oral, Vignette, and Poster Presentation submissions: November 21, 2019
Acceptance notification: February 1, 2020. Please note: notification may take up to one week from the notice date. If you have not received notice by February 11, 2020, please contact the Secretariat at annualmeeting@htai.org.

Confirmation of abstract submission will be received via email upon final submission.

Submission Details

a) General submission details:

b) Workshop and Panel submission details:

c) Oral, Vignette, and Poster submission details:

Review, acceptance, notification and final inclusion in the official Program

a) Review: All abstracts will be peer reviewed by three experts identified by the HTAi International Scientific Program Committee (ISPC). Workshop and panel submissions will be reviewed by members of the ISPC. Oral, vignette, and poster submissions will be reviewed by a broad group of reviewers, coordinated by the HTAi Secretariat, which will include ISPC members and a selected group of experts in the HTA field. Final decisions about inclusion and organization of the program will be made by the ISPC, led by the ISPC Co-Chairs.

b) Abstract acceptance and notifications:

c) Final inclusion in the official Annual Meeting Program:

Publication of abstract content

a) Annual Meeting Materials:

Submission of abstracts constitutes all authors’ consent to have their abstracts published on the HTAi 2020 website, mobile app, within the program and abstract book.

Please review your abstract prior to submission; check grammar and spelling and ensure all special characters and formatting display correctly. Accepted abstracts will be published in the Annual Meeting Materials (e.g. website, mobile app, program and abstract book) as submitted. Changes to abstracts will not be accepted after the submission deadline.

b) Supplementary Issue of the International Journal of Technology Assessment in Health Care:
Accepted abstracts of oral, vignette, and poster presentations have the possibility to be published in a Supplementary Issue of the International Journal of Technology Assessment in Health Care. Abstract submitters will be able to provide their consent for publication in the abstract submission form. Once abstracts have been accepted for the official program, there will be an editing process and if any major changes are recommended these will be communicated to the abstract submitter (primary contact). If authors would like to have their abstracts appear in the Supplement of IJTAHC, then a fully completed copyright form must be provided. Link to the Copyright Assignment Form. The Supplement will be produced several months after the meeting.


Scoring Criteria

The scoring system applied to all abstracts will take into consideration gender balance, the involvement of students and contributions from people from Low and Middle-Income Countries (LMIC) as well as patients, users, and clients.

a) Appropriateness to HTAi

The concept of the abstract should be appropriate to HTAi and in alignment with the main themes of the Annual Meeting. Workshops and panels should have presenters who are knowledgeable about the subject matter and, collectively, represent a variety of different perspectives and/or settings.

b) Original and Innovative Contribution

Abstracts with original and innovative ideas will receive a higher score. In particular: challenging existing paradigms or HTA practice, addressing an innovative hypothesis or critical barriers/issues to progress, and developing or enhancing novel concepts, approaches or methodologies, tools, or technologies for this area.

c) Abstract Structure and Quality

1) Workshop and panel abstracts must have the following structure:

Title: must not exceed 18 words, with no abbreviations, and the beginning of each word capitalized.

Background: Include the scientific background and rationale for the workshop or panel, and a clear statement of the issue. Must be clearly stated to achieve the highest score.

Structure of the session: Give the structure of your workshop/panel (e.g. presenters, timing, format of interaction, etc.) and your plans to generate a vibrant discussion or learning environment.

Workshop/Panel outcome and objectives: Explain what you would like to accomplish during your workshop/panel session, the session’s contribution to HTA capacity building as well as the benefits and takeaways for the audience or participants.

Moderators/Presenters: Include name, organization, position of all presenters, as well as the title (or brief description) of their specific contribution. Only confirmed moderators/presenters can be submitted with your application.

Declaration of funding: Please declare sources of funding of the research.

Basic quality: Workshops and panel abstracts should be appropriately summarized, and grammar and spelling should be checked.

2) Oral, vignette, and poster abstracts must have the following structure:

Title: must not exceed 18 words, with no abbreviations, and the beginning of each word capitalized.

Background: Include the scientific background and rationale, and give a clear statement of the problem, issue, study goal, objectives, and/or research hypothesis. Must be clearly stated to achieve the highest score.

Methods: For quantitative and related studies, include a clear statement of the perspective, data collected, sources of data, analyses including statistical testing, etc. Clearly describe the populations studied, method of accrual and sample frame and analytical techniques. For conceptual, institutional, organizational or policy papers, provide a concise description of the content of the paper or report to be presented and other relevant factors such as policy analysis of alternatives, details of qualitative methods, etc.

Results: Present the most important study findings including generalizability to other populations, health systems or countries if relevant. Abstracts must reflect work that has already been done (i.e. results available) or at least provide preliminary results suggesting that the work is in progress and that results will be available to present at the Annual Meeting.

Conclusions: Provide a concise statement on the most important findings or policy implications.  You should also address the question, “What do these results mean for your main area of research?” If relevant, include next steps, proposals for further research and study limitations.

Declaration of funding: Please declare sources of funding of the research.

Basic quality: Oral, vignette, and poster abstracts should be appropriately summarized, and grammar and spelling should be checked.


Style Guidelines

Please consider the following style guidelines as a general direction in the submission process to have the abstracts submitted as consistent and standardized for Annual Meeting publications (website, mobile app, program, and abstract book). These guidelines are in line with those required for abstracts to be included in the Supplementary Issue of the International Journal of Technology Assessment in Health Care (IJTAHC).


Things to keep in mind:



Why can’t I log in with my HTAi log in details?

HTAi is using a new submission system this year. As such, you will need to create a profile and a new log in ID / Password.

Why can’t I find the draft abstract that I had saved?

The system is set up with 2 separate portals: one for the Panels & Workshops and one for OVP.   If you have saved the draft for Panels & Workshops, you will need to first go to the “Abstract Submission” tab and ensure you are in the “Abstract Submission Portal for Panels & Workshops”.  If you are not, please select the correct portal under the “Abstract Submissions” tab.  Once you are in the correct portal, you can click “View/Edit Abstracts” to see your abstracts.   Please see image below.


Why can’t I find the  Authors / Co-Authors Affiliations as well as the Country fields in the portal?

The system has certain field limitations and currently the fields are not in the Panel & Workshops portal.  The service provider is currently trying to rectify this.  In the meantime, once you have submitted your abstract(s), please send an email to HTAI2020-abstracts@icsevents.com  to provide us with the information and we will update it on the back end.

Why won’t the system allow me to submit my abstract after I’ve completed all the sections?

Please check your word limit for each section as displayed on the abstract submission portal. The system won’t allow you to submit an abstract that is over the word limit for a specific section.